Platelets and microtubules. Effect of colchicine and D2O on platelet aggregation and release induced by calcium ionophore A23187
- PMID: 6772671
- PMCID: PMC371709
- DOI: 10.1172/JCI109855
Platelets and microtubules. Effect of colchicine and D2O on platelet aggregation and release induced by calcium ionophore A23187
Abstract
We examined the role of microtubules in platelet aggregation and secretion (release reaction) induced by the calcium ionophore A23187 (0.8-5 muM). At these concentrations, platelet aggregation was preceded by a lag period of approximately 1 min. Colchicine (an agent that disrupts microtubule assembly-disassembly) was shown to bind to platelet microtubules by employing [(3)H]colchicine at a concentration that is specific for microtubules in other tissues (10 nM). Colchicine prolonged the lag period, inhibited the secondary wave of platelet aggregation, and inhibited the release reaction (release of [(14)C]serotonin). Platelets were next incubated with 20-60% D(2)O, an agent that stabilizes microtubules. D(2)O overcame colchicine-induced inhibition of the lag period, aggregation, and release. D(2)O alone enhanced platelet aggregation by 59+/-14% (SEM) and shortened the lag period by 43+/-10%. We conclude that functioning microtubules are required for platelet aggregation and release, and that microtubules of platelet preparations are functioning submaximally.
Similar articles
-
Ionophore-induced disassembly of blood platelet microtubules: effect of cyclic AMP and indomethacin.J Cell Physiol. 1980 May;103(2):289-98. doi: 10.1002/jcp.1041030214. J Cell Physiol. 1980. PMID: 6254997
-
Inhibition of human platelet functions by verapamil.Thromb Haemost. 1981 Apr 30;45(2):158-61. Thromb Haemost. 1981. PMID: 6789494
-
Microtubule inhibitors alter the secretion of beta-glucuronidase by human blood platelets: involvement of microtubules in release reaction II.J Cell Physiol. 1978 Jul;96(1):43-52. doi: 10.1002/jcp.1040960106. J Cell Physiol. 1978. PMID: 659519 No abstract available.
-
Effects of a microtubule stabilizing agent on the response of platelets to vincristine.Blood. 1982 Aug;60(2):474-83. Blood. 1982. PMID: 6124288 Review.
-
Colchicine as a Modulator of Platelet Function: A Systematic Review.Semin Thromb Hemost. 2022 Jul;48(5):552-567. doi: 10.1055/s-0042-1749660. Epub 2022 Jul 26. Semin Thromb Hemost. 2022. PMID: 35882248
Cited by
-
Anti-inflammatory therapy for COVID-19 infection: the case for colchicine.Ann Rheum Dis. 2021 May;80(5):550-557. doi: 10.1136/annrheumdis-2020-219174. Epub 2020 Dec 8. Ann Rheum Dis. 2021. PMID: 33293273 Free PMC article. Review.
-
Combining Colchicine and Antiplatelet Therapy to Tackle Atherothrombosis: A Paradigm in Transition?Int J Mol Sci. 2025 Jan 28;26(3):1136. doi: 10.3390/ijms26031136. Int J Mol Sci. 2025. PMID: 39940905 Free PMC article. Review.
-
Colchicine for COVID-19: targeting NLRP3 inflammasome to blunt hyperinflammation.Inflamm Res. 2022 Mar;71(3):293-307. doi: 10.1007/s00011-022-01540-y. Epub 2022 Feb 3. Inflamm Res. 2022. PMID: 35113170 Free PMC article. Review.
-
The Role of Colchicine in Atherosclerosis: From Bench to Bedside.Pharmaceutics. 2022 Jul 1;14(7):1395. doi: 10.3390/pharmaceutics14071395. Pharmaceutics. 2022. PMID: 35890291 Free PMC article. Review.
-
Perspective: Collagen induced platelet activation via the GPVI receptor as a primary target of colchicine in cardiovascular disease.Front Cardiovasc Med. 2023 Jan 19;9:1104744. doi: 10.3389/fcvm.2022.1104744. eCollection 2022. Front Cardiovasc Med. 2023. PMID: 36741844 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources